Xilis Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
65
- Latest Deal Type
-
Out of Business
Xilis General Information
Description
Developer of micro-organ sphere technology designed to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables rapid diagnostics, personalized drug screening, and scalable patient-derived models for high-throughput drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening at a lower cost.
Contact Information
Website
www.xilis.comCorporate Office
- 31 Alexandria Way
- Durham, NC 27713
- United States
Corporate Office
- 31 Alexandria Way
- Durham, NC 27713
- United States
Xilis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 06-Sep-2026 | Completed | Out of Business | |||
| 7. Later Stage VC (Series AA) | 25-Apr-2025 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 13-Jul-2022 | Completed | Generating Revenue | |||
| 5. Grant | 09-May-2022 | Completed | Generating Revenue | |||
| 4. Seed Round | 21-May-2020 | Completed | Generating Revenue | |||
| 3. Debt - PPP | 30-Apr-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | $250K | $400K | Completed | Startup | ||
| 1. Seed Round | 26-Sep-2019 | $150K | $150K | Completed | Startup |
Xilis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 612,969 | $0.000200 | $0.25 | $0.25 | $0.25 | 1.8% | ||
| Seed-1 | 5,103,640 | $0.000200 | $0.96 | $0.96 | $0.96 | 15.01% |
Xilis Comparisons
Industry
Financing
Details
Xilis Competitors (18)
One of Xilis’s 18 competitors is Valo, a Venture Capital-Backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Valo | Venture Capital-Backed | Lexington, MA | ||||
| NuMedii | Formerly VC-backed | San Mateo, CA | ||||
| Genesis Molecular AI | Venture Capital-Backed | San Mateo, CA | ||||
| Chemical Computing Group | Private Equity-Backed | Montreal, Canada | ||||
| X-37 | Venture Capital-Backed | South San Francisco, CA |
Xilis Patents
Xilis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4677359-A1 | Cell labeling and annotation in micro-organospheres | Pending | 03-Mar-2023 | ||
| US-20260243775-A1 | Cell labeling and annotation in micro-organospheres | Pending | 03-Mar-2023 | ||
| WO-2024191617-A1 | Cell labeling and annotation in micro-organospheres | Inactive | 03-Mar-2023 | ||
| JP-2026507182-A | Labeling and annotation of cells in microorganospheres | Pending | 03-Mar-2023 | ||
| US-11986827-B2 | Closed loop control of microfluidic systems | Active | 11-Oct-2022 | B01L3/502784 |
Xilis Signals
Xilis FAQs
-
When was Xilis founded?
Xilis was founded in 2019.
-
Where is Xilis headquartered?
Xilis is headquartered in Durham, NC.
-
What is the size of Xilis?
Xilis has 65 total employees.
-
What industry is Xilis in?
Xilis’s primary industry is Discovery Tools (Healthcare).
-
Is Xilis a private or public company?
Xilis is a Private company.
-
What is Xilis’s current revenue?
The current revenue for Xilis is .
-
How much funding has Xilis raised over time?
Xilis has raised $115M.
-
Who are Xilis’s competitors?
Valo, NuMedii, Genesis Molecular AI, Chemical Computing Group, and X-37 are some of the 18 competitors of Xilis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process